サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1655425

ナノバイオテクノロジーの世界市場

Nanobiotechnology

出版日
ページ情報
英文 212 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ナノバイオテクノロジーの世界市場
出版日: 2025年02月14日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 212 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ナノバイオテクノロジーの世界市場、2030年には1,788億米ドルに到達へ

2024年に1,194億米ドルと推定されるナノバイオテクノロジーの世界市場は、2030年には1,788億米ドルに達し、分析期間2024-2030年のCAGRは7.0％で成長すると予測されます。本レポートで分析したセグメントの1つである医薬品・バイオテクノロジー産業エンドユーズは、CAGR 7.6%を記録し、分析期間終了時には1,227億米ドルに達すると予測されます。医療機器エンドユーズ分野の成長率は、分析期間中CAGR 5.7%と推定されます。

米国市場は332億米ドル、中国はCAGR6.5%で成長予測

米国のナノバイオテクノロジー市場は、2024年に332億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに276億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.6%と5.3%と予測されています。欧州では、ドイツがCAGR 5.6%で成長すると予測されています。

世界のナノフィルム市場- 主要動向と促進要因のまとめ

ナノフィルムとは何か、どのように産業に革命をもたらすのか？

ナノフィルムとは、機能性や性能を高めるために表面に塗布される、厚さ数ナノメートルの超薄膜のことです。これらのフィルムは、金属、セラミック、ポリマーなどのさまざまな材料で構成され、それぞれが高い導電性、卓越した強度、耐腐食性、耐摩耗性などのユニークな特性を備えています。その用途は多岐にわたり、エレクトロニクス、ヘルスケア、エネルギー、自動車などの産業分野に及んでいます。例えばエレクトロニクス分野では、ナノフィルムは画面の輝度や色彩の質を高めることで、スマートフォンやテレビなどの機器の効率や性能を向上させるために使用されています。ヘルスケア分野では、ナノフィルムはより効率的なドラッグデリバリーシステムや高度な診断ツールの開発に貢献しています。

技術の進歩はナノフィルム開発にどのような影響を与えているか？

技術の進歩は、ナノフィルムの開発、特にその製造と応用に用いられる方法において、極めて重要な役割を果たしています。原子層堆積法（ALD）、化学気相成長法（CVD）、物理気相成長法（PVD）などの技術により、これらの膜の厚さや組成を精密に制御することが可能になり、特定の産業ニーズに合わせたオーダーメイドのソリューションが実現します。ナノテクノロジーの革新は、温度、光、圧力などの環境刺激に反応できるスマートナノフィルムの創出にもつながっています。このような応答性フィルムは、センサーやウェアラブル技術にますます使用されるようになっており、デバイスの機能性やユーザーとのインタラクションを高める適応特性を提供しています。

ナノフィルムの将来を形作る市場動向とは？

ナノフィルム市場は、需要と供給の力学の両方に影響を与えるいくつかの重要な動向によって形成されています。大きな動向のひとつは、高性能で小型化された電子機器に対する需要の高まりです。デバイスが小型化し、その機能が高まるにつれて、小型化した寸法で性能を発揮できる高度な材料の必要性が高まっています。ナノ薄膜は、薄い層で高性能を実現することにより、このような要求を満たし、小型電子機器に理想的な材料となっています。もう一つの動向は、持続可能性への関心の高まりであり、ソーラーパネルやエネルギー効率の高い窓に使用されるような、エネルギー効率に貢献するナノフィルムへの関心を高めています。さらに、自動車業界の電気自動車へのシフトにより、軽量で耐久性のある材料へのニーズが高まっており、ナノフィルムはバッテリーの寿命や自動車の性能を高めるために使用されています。

ナノフィルム市場の成長の原動力は？

ナノフィルム市場の成長は、ナノテクノロジーと材料科学の継続的な進歩、様々な産業におけるナノフィルムの品質と適用性の向上など、いくつかの要因によってもたらされます。より小さく、より速く、より効率的なデバイスへの絶え間ない要求で活況を呈するエレクトロニクス分野は、これらの要求を満たすためにナノフィルム技術に大きく依存しています。さらに、エネルギー分野、特に太陽エネルギー用途でのナノフィルムの利用が増加しており、世界がより再生可能なエネルギー源に向かっていることから、市場の成長を支えています。特に、高性能で耐久性があり、エネルギー効率の高い製品を求める消費者が増えているためです。さらに、環境の持続可能性を促進する規制動向は、環境負荷の低減に役立つナノフィルムのような革新的材料の採用を奨励しています。これらの要因が総体的にナノフィルム市場のダイナミックな拡大を後押ししており、これは現代の技術応用におけるナノフィルムの不可欠な役割を反映しています。

セグメント

最終用途（医薬品・バイオテクノロジー産業、医療機器）

調査対象企業の例（全79件）

  • Ablynx NV
  • Arrowhead Pharmaceuticals Inc.
  • CaPtivate Pharmaceuticals LLC
  • Celgene Corporation
  • ELITechGroup
  • Flamel Technologies SA
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • NanoBio（R）Corporation
  • Nanophase Technologies Corporation
  • pSivida Corp.
  • Sigma-Aldrich Corp.
  • Starpharma Holdings Ltd.
  • Vectura Group plc

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP-1476

Global Nanobiotechnology Market to Reach US$178.8 Billion by 2030

The global market for Nanobiotechnology estimated at US$119.4 Billion in the year 2024, is expected to reach US$178.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Pharmaceuticals & Biotechnology Industry End-Use, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$122.7 Billion by the end of the analysis period. Growth in the Medical Devices End-Use segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$33.2 Billion While China is Forecast to Grow at 6.5% CAGR

The Nanobiotechnology market in the U.S. is estimated at US$33.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.6 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.6% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Nanofilms Market - Key Trends & Drivers Summarized

What Are Nanofilms and How Are They Revolutionizing Industries?

Nanofilms are ultra-thin layers of material, often just a few nanometers thick, applied to surfaces to enhance their functionality or performance. These films can be composed of different materials, including metals, ceramics, and polymers, each offering unique properties such as high conductivity, exceptional strength, and resistance to corrosion and wear. Their applications are diverse and span across industries including electronics, healthcare, energy, and automotive. In electronics, for instance, nanofilms are used to improve the efficiency and performance of devices like smartphones and TVs by enhancing screen brightness and color quality. In the healthcare sector, nanofilms contribute to the development of more efficient drug delivery systems and advanced diagnostic tools.

How Are Technological Advancements Influencing Nanofilm Developments?

Technological advancements play a pivotal role in the development of nanofilms, particularly in the methods used for their fabrication and application. Techniques such as atomic layer deposition (ALD), chemical vapor deposition (CVD), and physical vapor deposition (PVD) allow for precise control over the thickness and composition of these films, enabling tailor-made solutions for specific industry needs. Innovations in nanotechnology have also led to the creation of smart nanofilms, which can respond to environmental stimuli such as temperature, light, and pressure. These responsive films are increasingly used in sensors and wearable technology, offering adaptive properties that enhance device functionality and user interaction.

What Market Trends Are Shaping the Future of Nanofilms?

The nanofilm market is being shaped by several significant trends that are influencing both demand and supply dynamics. One of the major trends is the increasing demand for high-performance, miniaturized electronics. As devices become smaller and their functionality increases, the need for advanced materials that can perform at these reduced dimensions grows. Nanofilms meet these requirements by enabling high performance in thin layers, making them ideal for compact electronic devices. Another trend is the growing focus on sustainability, driving interest in nanofilms that contribute to energy efficiency, such as those used in solar panels and energy-efficient windows. Additionally, the automotive industry's shift towards electric vehicles has increased the need for lightweight, durable materials, where nanofilms are used to enhance battery life and vehicle performance.

What Drives the Growth of the Nanofilm Market?

The growth in the nanofilm market is driven by several factors, including the continued advancement of nanotechnology and material science, which enhances the quality and applicability of nanofilms across various industries. The booming electronics sector, with its constant demand for smaller, faster, and more efficient devices, heavily relies on nanofilm technology to meet these requirements. Additionally, the increasing utilization of nanofilms in the energy sector, particularly in solar energy applications, supports market growth as the world moves towards more renewable energy sources. Consumer behavior also influences this growth, especially as more consumers demand high-performance, durable, and energy-efficient products. Moreover, regulatory trends promoting environmental sustainability encourage the adoption of innovative materials like nanofilms to help reduce environmental impact. These factors collectively drive the dynamic expansion of the nanofilm market, reflecting its integral role in modern technological applications.

SCOPE OF STUDY:

The report analyzes the Nanobiotechnology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Pharmaceuticals & Biotechnology Industry, Medical Devices)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 79 Featured) -

  • Ablynx NV
  • Arrowhead Pharmaceuticals Inc.
  • CaPtivate Pharmaceuticals LLC
  • Celgene Corporation
  • ELITechGroup
  • Flamel Technologies SA
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • NanoBio(R) Corporation
  • Nanophase Technologies Corporation
  • pSivida Corp.
  • Sigma-Aldrich Corp.
  • Starpharma Holdings Ltd.
  • Vectura Group plc

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Nanobiotechnology - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Nanotechnology Propel Growth in Nanobiotechnology Market
    • Increasing Demand for Targeted Drug Delivery Expands Addressable Market Opportunity
    • Growth in Diagnostic and Imaging Applications Generates Demand for Nanobiotechnology Solutions
    • Technological Innovations in Nanomedicine Strengthen Business Case for Nanobiotechnology
    • Integration of Nanomaterials in Regenerative Medicine Spurs Growth in Healthcare Sector
    • Demand for Precision Medicine Expands the Market for Nanobiotechnology
    • Advances in Nano-Scale Imaging and Sensing Technologies Generate Demand for Innovative Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Nanobiotechnology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Nanobiotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pharmaceuticals & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Pharmaceuticals & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Pharmaceuticals & Biotechnology Industry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: USA 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: Canada 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • JAPAN
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: Japan 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • CHINA
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: China 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • EUROPE
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Nanobiotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Europe 15-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • FRANCE
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: France 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • GERMANY
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Germany 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Italy 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: UK 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 41: Rest of Europe Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Rest of Europe Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Rest of Europe 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 44: Asia-Pacific Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Asia-Pacific Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Asia-Pacific 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 47: Rest of World Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of World Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Rest of World 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030

IV. COMPETITION